People with mental illness and/or SUD are disproportionally affected by HIV. They may participate in behaviours that increase risk for contracting and transmitting HIV, such as sharing injection drug equipment or...
World AIDS Day takes place in December each year. This reading list contains a list of research, publications and resources for practitioners relating to HIV/Aids. We also have a network dedicated to HIV and HCV where you can find a...
This side event for the 65th Commission on Narcotic Drugs was originally presented on 14 March, 2022. Organised by INPUD, it was co-sponsored by Médecins du Monde, UNAIDS, UNODC HIV/AIDS Section, the Netherlands and Australia.
In 2021...
This summary page, developed by HIV info and NIH’s Office of AIDS Research, explores HIV and substance use.
The fact sheet addresses the following questions:
Sharing drug injecting equipment increases the risk of transmitting and acquiring blood-borne infections, such as HIV and hepatitis B and C. While hepatitis C is the most prevalent blood-borne viral infection among people who inject drugs...
A new publication by UNAIDS and the World Health Organization (WHO) emphasizes the importance of integrating HIV and mental health services and other interventions, including linkages to social protection services, for people living with...
The 2021-2026 Global AIDS Strategy has bold and critical new targets on realizing human rights, reducing stigma, discrimination and violence and removing harmful punitive laws as a pathway to ending inequalities and ultimately ending AIDS.
...
Since the beginning of the HIV epidemic, the focus on HIV prevention, treatment and care among people who use drugs has concentrated on the needs of people who inject drugs, and mainly on those who inject opioids. However, data show that...
There is a higher prevalence of substance use disorder (SUD) among justice-involved children (JIC). It is critical to ensure that JIC who report current use are referred for SUD assessment and potentially life-saving treatment...
There is increasing interest and evidence for the use of cannabinoid medications in the treatment of cannabis use disorder, but little examination of the correlates of successful treatment. This paper is a secondary analysis...
